The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction
Konstantinopoulos, Angelis, Giannitsas, Konstantinos, Athanasopoulos, Anastasios, Spathas, Dionisios, Perimenis, Petros
Published in Expert opinion on pharmacotherapy (01.02.2009)
Published in Expert opinion on pharmacotherapy (01.02.2009)
Get more information
Journal Article
Endothelial dysfunction, erectile dysfunction and phosphodiesterase 5 inhibitors. An update of the current data and future perspectives
Konstantinopoulos, Angelis, Giannitsas, Konstantinos, Raptis, Spiros, Perimenis, Petros
Published in Drug target insights (01.01.2007)
Published in Drug target insights (01.01.2007)
Get full text
Journal Article
Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
Konstantinopoulos, Angelis, Giannitsas, Konstantinos, Raptis, Spiros, Perimenis, Petros
Published in Drug Target Insights (01.01.2007)
Published in Drug Target Insights (01.01.2007)
Get full text
Book Review
Journal Article
Phosphodiesterase-5 inhibitors in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia
Giannitsas, Konstantinos, Mitropoulos, Dionisios, Konstantinopoulos, Angelis, Athanasopoulos, Anastasios, Perimenis, Petros
Published in Expert opinion on pharmacotherapy (01.07.2008)
Published in Expert opinion on pharmacotherapy (01.07.2008)
Get more information
Journal Article